IRD — Opus Genetics, Inc.

IRDOpus Genetics, Inc.

NAS · US · Healthcare · Biotechnology · opusgtx.com

4.105USD-3.64%Mkt Cap: 333.31M USDP/E: —Last update: 2026-05-26

Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additio…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap333.31M USD

Enterprise Value272.29M USD

Revenue (TTM)11.98M USD

Gross Profit-18.83M USD

Net Income (TTM)-49.59M USD

Revenue/Share0.1590 USD

Last Price4.105 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees27

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-6.11

PEG—

EV/EBITDA-6.33

EV/Revenue22.72

P/S29.14

P/B-6.68

EPS (TTM)-1.31

EPS (Forward)-0.70

52W Range

0.900065% of range5.810

52W High5.810 USD

52W Low0.9000 USD

Profitability

Gross Margin-157.13%

Oper. Margin-665.92%

EBITDA Margin0.00%

Profit Margin-349.33%

ROE-323.11%

ROA-98.70%

Growth

Revenue Growth-50.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-35.25M USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-58.76M USD

Net Debt/EBITDA1.37

Balance Sheet

Debt/Equity0.07

Current Ratio7.13

Quick Ratio6.71

Book Value/Sh-0.6420 USD

Cash/Share0.8400 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateNov 6, 2020

Splits

Last Split1:4

Split DateNov 6, 2020

Analyst Consensus

Rating1.1 (Strong Buy)

Target (Mean)10.13 USD

Target Range8.000 USD – 15.00 USD

# Analysts15

Ownership

Shares Out.81.40M

Float34.48M

Insiders11.22%

Institutions55.81%

Short Interest

Short Ratio2.6d

Short % Float2.97%

Short % Out.2.80%

Shares Short2.00M

Short (prev mo.)1.85M

Technical

SMA 504.972 (-17.4%)

SMA 2002.881 (+42.5%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)890.63K

Avg Vol (10d)1.05M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—